Healthcare startups, and all startups for that matter, need investors and funding to stay alive. For this reason, MedCity is pleased to announce that investor Andrew Jay, MD, will be speaking at CONVERGE. Dr. Jay is the head of the medical solutions fund at HealthCare Fund at Siemens Venture Capital, which invests in companies focusing on imaging, diagnostics and health IT.
Jay will be speaking on the second day of MedCity CONVERGE at 9:20 a.m. The third annual CONVERGE is July 15-16 in Philadelphia.
Payers, providers, medtech, pharma, digital health, startups and investors will all come together at CONVERGE to focus on healthcare’s greatest opportunities and challenges. Check out the agenda and register today.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
To highlight the speakers before the conference, we asked them each a few questions.
What or who inspires your work in healthcare?
Healthcare gives me the opportunity to give back to society. Every day patients are being helped by companies I advised or funded. They are detecting cancer, treating diabetes, saving them in the ER or resuscitating people in cardiac arrest.
What do you think is the most important change happening in healthcare today?
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The most important trends are the emergence of bioinformatics. This will begin changing certain treatments, but it is not the all-encompassing tool some people imagine.
